SCHEMBL16234564

SCHEMBL16234564

C[C@H](CCc1ccc(O)cc1)O[C@@H]1OC(CO)[C@@H](O)C(O)[C@@H]1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 7/20 0.71
▸ PPARG P37231 3/20 0.68
▸ PPARD Q03181 3/20 0.68
▸ PPARA Q07869 3/20 0.68
▸ SYNJ2 O15056 2/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ MAPT P10636 2/20 0.54
▸ ABL1 P00519 1/20 0.54
▸ ALPL P05186 1/20 0.54
▸ POLB P06746 1/20 0.54
▸ ALPI P09923 1/20 0.54
▸ GAA P10253 1/20 0.54
▸ ALPG P10696 1/20 0.54
▸ PABPC1 P11940 1/20 0.54
▸ RECQL P46063 1/20 0.54
▸ GALK1 P51570 1/20 0.54
▸ CASP7 P55210 1/20 0.54
▸ CASP6 P55212 1/20 0.54
▸ MCL1 Q07820 1/20 0.54
▸ RIN1 Q13671 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28971367 1.00 TYR (0.71) TYRPPARGPPARDPPARASYNJ2
SCHEMBL5320094 1.00 TYR (0.71) TYRPPARGPPARDPPARASYNJ2
SCHEMBL329049 1.00 TYR (0.71) TYRPPARGPPARDPPARASYNJ2
SCHEMBL16233068 1.00 TYR (0.71) TYRPPARGPPARDPPARASYNJ2
SCHEMBL16167402 0.89 SYNJ2 (0.67) TYRPPARGPPARDPPARASYNJ2
SCHEMBL18821488 0.87 TYR (0.61) TYRPPARGPPARDPPARASYNJ2
SCHEMBL4652451 0.80 TYR (0.61) TYRPPARGPPARDPPARAKDM4E
SCHEMBL28707080 0.79 PPARG (0.60) TYRPPARGPPARDPPARASYNJ2
SCHEMBL27718878 0.79 PPARG (0.63) TYRPPARGPPARDPPARASYNJ2
SCHEMBL28007620 0.79 PPARG (0.60) TYRPPARGPPARDPPARASYNJ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140336135-A1 NOVEL USE OF RHODODENDRIN CATHOLIC UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION (KR) 2014-11-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336135-A1 NOVEL USE OF RHODODENDRIN TLR1, IFNG, ROS1 TYR 63/4885PPARG 475/4885PPARD 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback